Skip to main content
padlock icon - secure page this page is secure
Current Cancer Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular drug targets involved in cancer, e.g. disease specific proteins, receptors, enzymes, genes.
Each issue of the journal contains a series of timely in-depth reviews written by leaders in the field covering a range of current topics on drug targets involved in cancer.
As the discovery, identification, characterization and validation of novel human drug targets for anti-cancer drug discovery continues to grow; this journal has become essential reading for all pharmaceutical scientists involved in drug discovery and development.

Publisher: Bentham Science Publishers

More about this publication?
Volume 17, Number 1, 2017

Articles

Free Content Graphical Abstracts
pp. i-iv(4)

Favourites:
ADD

Free Content Meet Our Editorial Board Member
pp. 1-1(1)
Author: S.W. Tsao, G.

Favourites:
ADD
Favourites:
ADD

Novel Strategies to Discover Effective Drug Targets in Metabolic and Immune Therapy for Glioblastoma
pp. 17-39(23)
Authors: Wang, Gang; Fu, Xing-Li; Wang, Jun-Jie; Guan, Rui; Tang, Xiang-Jun

Favourites:
ADD

OncomicroRNAs-Mediated Tumorigenesis: Implication in Cancer Diagnosis and Targeted Therapy
pp. 40-47(8)
Authors: Zheng, Nana; Yang, Ping; Wang, Zhiwei; Zhou, Quansheng

Favourites:
ADD

Novel Synthetic Lethality Approaches for Drug Combinations and Early Drug Development
pp. 48-52(5)
Authors: Ocana, Alberto; Pandiella, Atanasio

Favourites:
ADD

Does Hypoxic Response Mediate Primary Resistance to Sunitinib in Untreated Locally Advanced Breast Cancer?
pp. 62-73(12)
Authors: Braga, Sofia; Cardoso, Joana; Andre, Saudade; Brito, Margarida; Sanchez, Pedro; Orvalho, Lurdes; Salgado, Lucilia; Dias, Sergio; B. Pereira-Leal, Jose; Luis Passos-Coelho, Jose

Favourites:
ADD

Strong Anti-tumorous Potential of Nardostachys jatamansi Rhizome Extract on Glioblastoma and In Silico Analysis of its Molecular Drug Targets
pp. 74-88(15)
Authors: Kapoor, Himanshi; Yadav, Nalini; Chopra, Madhu; Mahapatra, Sushil Chandra; Agrawal, Veena

Favourites:
ADD

EGFR High Expression, but not KRAS Status, Predicts Sensitivity of Pancreatic Cancer Cells to Nimotuzumab Treatment In Vivo
pp. 89-97(9)
Authors: Zhou, Chenfei; Zhu, Liangjun; Ji, Jun; Ding, Fangmi; Wang, Chao; Cai, Qu; Yu, Yingyan; Zhu, Zhenggang; Zhang, Jun

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more